LAM

HomePatientsLung Disease Week at the ATS2017LAM ▶ Information for Experts
Information for Experts

LAM Week

 

ClinicianATS Educational Products

 

2015

C9

INTERSTITIAL LUNG DISEASE: THE LATEST ON DIAGNOSIS AND MANAGEMENT

D7

BREATHMAKING PROGRESS IN RARE INTERSTITIAL LUNG DISEASES

 


 

ClinicianATS Journal articles on LAM

 

American Journal of Respiratory and Critical Care Medicine

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
(2016)
Read Abstract

Genetic Heterogeneity of Circulating Cells from Patients with Lymphangioleiomyomatosis with and without Lung Transplantation
Vol. 191, No. 7 (2015), pp. 854-856.
Read Abstract

Tuberous Sclerosis Complex 2 Loss of Heterozygosity in Patients with Lung Disease and Cancer
Vol. 191, No. 3 (2015), pp. 352-355.
Read Abstract

Chronic Sirolimus Therapy for Lymphangioleiomyomatosis
Vol. 190, No. 12 (2014), pp. 1332-1333.
Read Abstract

Sustained Effects of Sirolimus on Lung Function and Cystic Lung Lesions in Lymphangioleiomyomatosis
Vol. 190, No. 11 (2014), pp. 1273-1282.
Read Abstract

Lymphangioma Presenting as Hemoptysis in Pregnancy
Vol. 188, No. 3 (2013), pp. 397-398
Read Abstract

To Be or Not To Be a Neoplasm: What Is Lymphangioleiomyomatosis? Are We Calling It What It Really Is?
Vol. 188, No. 3 (2013), pp. 397-398
Read Abstract

Exonic Mutations of TSC2/TSC1 Are Common but Not Seen in All Sporadic Pulmonary Lymphangioleiomyomatosis
Vol. 187, No. 6 (2013), pp. 663-665
Read Abstract

 

American Journal of Respiratory Cell and Molecular Biology

Tuberous Sclerosis Complex 2 Loss Increases Lysophosphatidylcholine Synthesis in Lymphangioleiomyomatosis
Vol. 53, No. 1 (2015), pp. 33-41.
Read Abstract

Surfactant Dysfunction and Lung Inflammation in the Female Mouse Model of Lymphangioleiomyomatosis
Vol. 53, No. 1 (2015), pp. 96-104.
Read Abstract

Rapamycin-Resistant Poly (ADP-Ribose) Polymerase-1 Overexpression Is a Potential Therapeutic Target in Lymphangioleiomyomatosis
Vol. 51, No. 6 (2014), pp. 738-749.
Read Abstract

Reply: Hormonally Targeted Therapy for Women with Lymphangioleiomyomatosis
Vol. 50, No. 3 (2014), pp. 665.
Read Abstract

Is There Still a Role for Hormonal Blockade in Lymphangioleiomyomatosis?
Vol. 50, No. 3 (2014), pp. 665.
Read Abstract

The Antimalarial Drug Artesunate Inhibits Primary Human Cultured Airway Smooth Muscle Cell Proliferation
Vol. 50, No. 2 (2014), pp. 451-458.
Read Abstract

 

Annals of ATS

Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis
(2016)
Read Abstract

Imaging Biomarkers in Lymphangioleiomyomatosis Clinical Trials. A Wolf in Sheep’s Clothing?
(2016)
Read Abstract

A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air-trapping in Lymphangioleiomyomatosis
(2016)
Read Abstract

Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in Lymphangioleiomyomatosis
Vol. 12, No. 8 (2015), pp. 1247-1248.
Read Abstract

Kaposiform Lymphangiomatosis, a Newly Characterized Vascular Anomaly Presenting with Hemoptysis in an Adult Woman
Vol. 11, No. 1 (2014), pp. 92-95.
Read Abstract

 


 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below: